Caricamento...
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
The cannabinoid type-2 G protein-coupled (CB(2)) receptor is an emerging therapeutic target for pain management and immune system modulation. In a mouse model of Alzheimer’s disease (AD) the orally administered natural product 4′-O-methylhonokiol (MH) has been shown to prevent amyloidogenesis and pr...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3419612/ https://ncbi.nlm.nih.gov/pubmed/22716035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-9-135 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|